North Plainfield, NJ, United States of America

Walter Newman

This inventor holds 1 USPTO granted patent. Top assignee: Ortho Pharmaceutical Corporation. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Walter Newman. Retrieved from https://idiyas.com/inventor/walter-newman-kgwvr04f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Walter Newman: Innovator in Monoclonal Antibody Therapy

Introduction

Walter Newman is a notable inventor based in North Plainfield, NJ (US). He has made significant contributions to the field of medical therapies, particularly through his work on monoclonal antibodies. His innovative approach has the potential to enhance both therapeutic and diagnostic applications in medicine.

Latest Patents

Walter Newman holds a patent for a method of seriatim administration of a plurality of ligands, each containing an antigen combining site of a monoclonal antibody of distinct idiotype. This method is particularly useful for therapeutic as well as diagnostic purposes. His patent represents a significant advancement in the treatment of various medical conditions.

Career Highlights

Walter Newman is associated with Ortho Pharmaceutical Corporation, where he has been able to apply his expertise in developing innovative medical solutions. His work has contributed to the advancement of therapeutic techniques that utilize monoclonal antibodies.

Collaborations

Throughout his career, Walter has collaborated with esteemed colleagues, including Mary A. Talle and Patricia E. Rao. These collaborations have fostered an environment of innovation and have led to the development of groundbreaking medical therapies.

Conclusion

Walter Newman is a distinguished inventor whose work in monoclonal antibody therapy has the potential to transform medical treatments. His contributions to the field are invaluable and continue to inspire future innovations in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…